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ABSTRACT – ENGLISH 
The epithelial sodium channel (ENaC), consisting of various combinations of the 
four homologous subunits α, β, γ and δ, mediates the sodium transport across 
epithelial tissues. Delta-ENaC subunit mRNA and protein are present in the 
human lung tissue, raising the question about the physiological role of δ-ENaC in 
the lung. Therefore, we used a number of xenobiotics that have been suggested 
to be selective δ-ENaC modulators. The sodium-dependence of the alleged 
activators and inhibitors was confirmed by Ussing chamber experiments in 
sodium-free buffer. As the pharmacophores displayed different effects than 
published in previous papers, we further assessed the δ-ENaC specificity of the 
substances by knock-down as well as over-expression studies of δ-ENaC protein. 
In summary, our observations revealed that the compounds’ effects in the 
organotypic cell models most likely originated from modulation of other, yet 
unknown, targets. The identification of more specific δ-ENaC modulators is 
required in order to further study the functional expression as well as the 
physiological role of δ-ENaC in the lung epithelium and other tissues. 
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ABSTRACT – DEUTSCH 
Der epitheliale Natriumkanal (ENaC), der aus verschiedenen Kombinationen der 
homologen Untereinheiten α, β, γ und δ besteht, ist für den epithelialen 
Natriumtransport verantwortlich. Sowohl δ-ENaC mRNA als auch das Protein 
wurden in der menschlichen Lunge nachgewiesen; um die Expression und 
physiologische Rolle von δ-ENaC im epithelialen Lungengewebe näher zu 
untersuchen, haben wir eine Reihe von Pharmakophoren verwendet, die als δ-
ENaC Modulatoren beschrieben worden sind. Zuerst wurde die 
Natriumabhängigkeit der Agonisten und Antagonisten anhand von 
Ussingkammerexperimenten bestätigt. Da die ENaC-Modulatoren andere als die 
zuvor publizierten Ergebnisse lieferten, haben wir mit Hilfe von δ-ENaC 
Herabregulierung und Überexpression versucht die Spezifität der Modulatoren zu 
untersuchen. Alles in allem haben unsere Studien gezeigt, dass die durch die 
Substanzen hervorgerufenen Effekte wahrscheinlich durch die Interaktion mit 
anderen Zielstrukturen hervorgerufen werden. Aus diesem Grund ist es nötig 
weitere und spezifischere δ-ENaC Modulatoren zu identifizieren, um sowohl 
Expression als auch physiologische Funktion von δ-ENaC genauer untersuchen 
zu können. 
1 
1 INTRODUCTION AND BACKGROUND 
1.1 The epithelial sodium channel 
The epithelial sodium channel (ENaC) is an amiloride-sensitive, non-voltage 
gated ion channel, widely distributed throughout epithelial as well as non-
epithelial tissues. It belongs to the ENaC/degenerin superfamily of ion channels, 
members of which display a remarkable functional diversity including Na+ 
absorption, acid-sensing, peptide-gating, acidosis-evoked nociception and 
mechanotransduction. There have been 5 subunits (α, β, γ, δ, ε) cloned so far 
that are able to assemble in different combinations [1, 2]. 
 
1.1.1 The canonical ENaC (αβγ) 
The heteromeric channel, mostly found in epithelial tissue, consists of the three 
homologous subunits α, β and γ. Albeit sharing 34-37% of their amino acid 
sequence, each subunit is encoded by a different gene [3, 4, 5].  
Another common feature is the membrane topology, which is shown in Figure 1. 
ENaC subunits have two hydrophobic transmembrane regions (M1, M2) that are 
separated by an extracellular, hydrophilic loop with several glycosylation sites 
and a short intracellular amino as well as a carboxy terminus. The pre-M2 
segment is thought to be the pore-forming part in all ENaC subunits [2, 5, 6, 7]. 
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Figure 1 
ENaC structure and membrane topology. The canonical ENaC is composed of 3 
homologous subunits: α, β, and γ, in a tetrameric configuration. Subunits have similar 
membrane topology, characterised by two transmembrane domains (M1 and M2), an 
extracellular loop and cytoplasmic amino and carboxyl termini [8]. 
 
 
Canessa et al. demonstrated that β- or γ-ENaC are not able to induce amiloride-
sensitive Na+ currents on their own, whereas the expression of α-ENaC alone 
generated Na+ currents [4]. However, larger currents resulted from the 
combination of αβ- or αγ-ENaC. For maximal activity, the assembly of all three 
ENaC subunits is required. This has been proposed to be a tetrameric 2αβγ- or a 
nonameric 3α3β3γ-construct [9, 10]. 
 
The canonical ENaC (αβγ) is expressed in the cortical and collecting tubules of 
the kidney, distal colon, ducts of secretory glands and in distal and proximal 
airways. In these epithelia, it is localised to the apical cell membranes and 
provides - together with the basolateral Na+/K+-ATPase - a pathway for 
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transepithelial sodium transport. Therefore, ENaC plays a crucial role in 
controlling the body’s Na+ homeostasis and, hence, extracellular volume as well 
as blood pressure [1, 2, 11].  
In the respiratory tract, αβγ-ENaC is expressed from the nasal to the alveolar 
epithelium and plays a critical role at birth, when the lung changes from a liquid- 
to an air-filled organ [1, 12]. Hummler et al. demonstrated the importance of α-
ENaC in particular, since α-ENaC knockout mice died soon after birth from 
respiratory failure, caused by deficient liquid clearance from the lung [13]. 
Additionally, β- and γ-ENaC knockout mice displayed reduced, albeit sufficient, 
alveolar fluid clearance and died from hyperkalaemia due to abnormal K+-
reabsorption in the kidneys [14, 15]. 
 
1.1.2 The δ-ENaC subunit 
In addition to the above mentioned α-, β-, γ-ENaC subunits, there is a forth one, 
δ-ENaC, which has been cloned from the human kidney. In contrast to the 
canonical ENaC, this subunit is also widely distributed throughout non-epithelial 
tissues. The highest expression of δ-ENaC mRNA was found in testis, ovary, 
pancreas and brain; whereas, smaller amounts were detected for example in the 
kidney and lung [16]. Yamamura et al. confirmed the presence of δ-ENaC in 
heart, liver, pancreas, in the different parts of the brain, oesophagus, skin, 
skeletal muscle and in adult as well as foetal human kidney [17, 18, 19]. 
Furthermore, δ-ENaC has been described in cultured human epithelial cell lines 
of the pancreas (CFPAC), the colon (Caco-2) and the lung (H441 and A549) on 
mRNA as well as on protein levels (H441 and A549 cells) [20]. Finally, a recent 
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study by Bangel-Ruland et al. reported the presence of δ-ENaC in human nasal 
epithelium on the mRNA, protein and functional levels [21]. 
 
Regarding its amino acid sequence, δ-ENaC is closer related to α-ENaC (37% 
homology) rather than to β- and γ-subunits (27% and 29%, respectively). The 
transmembrane topology is identical for all four subunits [16].  
Expressed in X. laevis oocytes on its own, δ-ENaC, similar to α-ENaC, produced 
a Na+ current, which is around 50 times lower than the current induced by δβγ-
ENaC. However, unlike in the case of the α-ENaC subunit, no currents were 
generated when δ-ENaC was co-expressed with only α-, β- or γ-ENaC. 
Besides the tissue distribution, there are also differences between α- and δ-ENaC 
in the pharmacology and ion selectivity. In order to block δ-ENaC, significantly 
higher concentrations of amiloride and benzamil are needed. Also, δ-ENaC 
displayed a higher permeability for Na+ than it does for Li+, while both subunits 
were impermeable for K+ [16]. 
 
So far, little is known about the physiological role of δ-ENaC. Since it is activated 
by protons, Yamamura and colleagues have suggested that δ-subunit may act as 
a pH sensor in the human brain and oesophagus [17, 18, 22]. In inflamed and 
hypoxic tissue, δ-ENaC could be a part of a mechanism integrating external 
ischemic signals [23, 24]. Recent studies suggested that δ-ENaC may also act as 
a pH sensor in the lung and respond to noxious acidic aspiration [25]. 
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1.2 The electrophysiology of the epithelial lung tissue 
As described previously, epithelial sodium channels play an important role in 
alveolar fluid clearance at birth and in maintaining the lung fluid balance 
thereafter [13, 14, 15].  
On the one hand, epithelial lung tissue constitutes a barrier between an air-filled 
compartment and a vascular compartment. On the other hand, it facilitates the 
alveolar exchange of O2 and CO2. The alveolar lining layer, composed of 
surfactant and an aqueous subphase, is crucial to this process [26]. The balance 
between the passive fluid transport from the vascular compartment into the 
airways due to hydrostatic pressure and the liquid reabsorption, caused by the 
transepithelial Na+ uptake, creates the moist environment of the lung [27, 28]. 
 
Alveolar type I (ATI) and alveolar type II (ATII) epithelial cells, which cover 
approximately 99% of the internal surface of the lung, are the cellular sites of the 
major part of the alveolar ion and fluid absorption in the adult lung (Figure 2). ATI 
cells are large, squamous cells with very thin cytoplasmic extensions that cover 
about 98% of the internal lung surface [29]. They are involved in alveolar 
homoeostasis, lung development and remodelling, host defence, tumour-growth 
suppression, etc. [30, 31]. ATII cells are smaller, cuboidal cells that synthesise, 
secrete and re-uptake pulmonary surfactant [32]. As progenitor cells, they are 
also important in the process of repairing injured alveolar epithelium [33]. 
 
Prenatally, Cl- secretion is the main alveolar ion transport process that accounts 
for the lung being filled with liquid [34]. At birth, the pattern of alveolar fluid 
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secretion changes to that of fluid absorption, which is due to Na+ absorption 
becoming the predominant process [35]. 
Both ATI and ATII cells express functional ENaC and are involved in sodium 
absorption [36]. Sodium is absorbed via ENaC on the apical side of the 
epithelium and then actively transported across the basolateral membrane into 
the lung interstitium by the Na+/K+-ATPase. Thus, an osmotic gradient is 
generated that forces Cl- and water to follow via CFTR (cystic fibrosis 
transmembrane conductance regulator) channels and aquaporins, respectively. 
This process can be inhibited either by amiloride (ENaC-inhibitor) or ouabain 
(Na+/K+-ATPase-inhibitor) [29].  
 
In patch-clamp studies carried out in ATII cells, two distinct types of Na+ channels 
were detected: (i) the highly Na+-selective cation (HSC) channels, consisting of α-
, β- and γ-subunits, with a unit conductance of 4-6 pS and a Na+/K+-selectivity 
over 40 [37, 38] and (ii) non-selective cation (NSC) channels, composed of the α-
subunit alone and displaying a unit conductance of 19-24 pS and a Na+/K+ 
selectivity of approximately 1 [27, 38, 39, 40]. 
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Figure 2 
Schematic diagram of alveolar epithelial ion and fluid transport. Na+ is absorbed from the 
apical surfaces of both ATI and ATII cells via ENaC (HSC and NSC channels). 
Electroneutrality is conserved by Cl− movement through CFTR or CLC channels in ATII cells 
and/or paracellular influx, through tight-junctions. Na+ is transported from the basal surface 
of both cell types into the interstitial space by Na+/K+-ATPase. If net ion transport occurs 
from the apical surface to the interstitium, an osmotic gradient is created. This gradient in 
turn directs water transport in the same direction, either through aquaporins or by diffusion 
[41]. 
 
However, additional amiloride-sensitive cationic channels with various 
physiological properties have also been reported, which contribute to the diversity 
of pulmonary channel expression and function [36, 42]. 
Junor et al. discovered that, although amiloride completely abolished basal liquid 
resorption in neonatal sheep, the process became less sensitive to amiloride in 
adult sheep [43]. Furthermore, studies in adult rats revealed that only 30% of the 
baseline lung fluid absorption was blocked by silencing the α-ENaC expression 
using RNAi and the remaining fluid absorption was not inhibited by amiloride [44]. 
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These observations indicate that the canonical ENaC becomes less important in 
the lung fluid absorption as the lung changes from neonatal to adult life [29]. 
 
The recent evidence for presence of δ-ENaC in human respiratory epithelial cells 
on mRNA and protein levels, taken together with the observation that the major 
part of the baseline lung fluid absorption is not mediated by α-ENaC and displays 
smaller sensitivity to amiloride in the adult lung, raised the question, whether δ-
ENaC contributes to the variety of sodium conductances and, thus, to the fluid 
clearance in the lung. 
 
1.3 Pharmacological modulators of ENaC function 
Pharmacological tools available to distinguish between α- and δ-ENaC mediated 
currents are limited to date and are presented below.  
 
Non-selective pore blocker: amiloride (Figure 3) 
Amiloride is a potassium-sparing diuretic that is mainly used to treat hypertension 
and congestive heart failure. 
 
 
Figure 3 
3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide 
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It blocks the aldosterone-sensitive sodium absorption by reducing the mean open 
time of the ENaC channel in the kidney and decreases the potassium excretion in 
the distal nephron [45].  
Both, δ-ENaC as well as α-ENaC, channels are inhibited by amiloride; however, 
δβγ-ENaC is 30-fold less sensitive (K0.5 = 2.6 µM) to amiloride than αβγ-ENaC 
channels (K0.5 = 80 nM), making it possible to distinguish between α-ENaC and δ-
ENaC induced currents [16]. 
 
Selective antagonist: Evans blue (Figure 4) 
Evans blue is a non-toxic azo-dye that is used to study blood vessel and cellular 
membrane permeability as well as to measure the blood volume due to its high 
affinity to albumin [46]. 
 
 
Figure 4 
Tetrasodium (6E,6'E)-6,6-[(3,3'-dimethylbiphenyl-4,4'-diyl)di(1E)hydrazin-2-yl-1-
ylidene]bis(4-amino-5-oxo-5,6-dihydronaphthalene-1,3-disulfonate) 
 
Evans blue inhibited the inward currents generated by δβγ-ENaC, heterologously 
expressed in Xenopus laevis oocytes in a concentration-dependent manner with 
an IC50 of 143 μM. Additionally, the homomeric δ-ENaC channel was also 
blocked by Evans blue, however, not the αβγ-ENaC. The latter even showed a 
slight increase in activity in response to Evans blue [47]. 
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Selective agonists: capsazepine and icilin (Figure 5 and Figure 6) 
Capsazepine was developed as a synthetic analogue of the sensory neuron 
excitotoxin, capsaicin. It is a competitive antagonist for the transient receptor 
potential vanilloid subfamily 1 (TRPV1) and, therefore, a competitive antagonist 
of capsaicin as well as the more potent resiniferatoxin [48, 49, 50]. 
At micromolar concentrations, it also blocks voltage-dependent calcium and 
potassium channels [51, 52] as well as nicotinic acetylcholine receptors [53]. 
 
 
Figure 5 
(2-[2-(4-chlorphenyl)ethylamino-thiocarbonyl]-7,8-dihydroxy-2,3,4,5-tetrahydro-lH-2 
benzazepine) 
 
More recently, it was reported that capsazepine also potentiates the activity of the 
human δβγ-ENaC in a concentration-dependent manner with an EC50 of 8 μM. 
The effect of capsazepine is reversible and amiloride-sensitive [54]. 
 
Icilin is a super-cooling agent, acting as an agonist for the transient receptor 
potential melastatin subfamily 8 (the cold-receptor) and ankyrin-like subfamily 1 
[55, 56, 57]. 
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Figure 6 
1-(2-Hydroxyphenyl)-4-(3-nitrophenyl)-1,2,3,6-tetrahydropyrimidin-2-one 
 
Yamamura and co-workers have shown that icilin activates the human δβγ-ENaC 
in a concentration-dependent manner with an EC50 of 33 μM. The application of 
icilin increased the inward currents in δβγ-ENaC expressing X. laevis oocytes 
significantly. This effect was abolished by amiloride or by the removal of external 
Na+ [58]. 
 
All in all, capsazepine and icilin acted as activators for the heteromeric human 
δβγ-ENaC as well as for the homomeric δ-ENaC in X. laevis oocytes, but caused 
a slight decrease in the inward currents mediated by αβγ-ENaC. 
This led to the conclusion that both compounds were selective δ-ENaC activators 
and may also be used to elucidate the functional role of the channel in more 
complex cell and tissue models [54, 58]. 
 
1.4 Aim 
The objective of this project was to investigate the expression, cellular 
localisation and the function of δ-ENaC in human respiratory epithelial cells in 
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vitro. In particular, we aimed to test the specificity of the alleged δ-ENaC 
modulators in H441 and Calu-3 cells. To this end, δ-ENaC downregulation (in 
H441 and Calu-3 cells) as well as δ-ENaC overexpression (in H441 cells only) 
were performed, and the effects thereof were studied on protein as well as on the 
functional levels. Furthermore, the effects of the reported δ-ENaC modulators in 
H441 were evaluated in regards to their sodium dependence. 
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2 MATERIALS AND METHODS 
2.1 Materials 
Rabbit anti-δ-ENaC polyclonal antibodies, used in this work, were purchased 
from Santa Cruz Biotechnology (sc-21015, Heidelberg, Germany) or kindly 
provided by Dr. Diego Alvarez de la Rosa (Universidad de La Laguna, La 
Laguna, Spain). All other primary antibodies were obtained from Millipore (mouse 
anti-Na+/K+-ATPase α-1 clone C464.6 monoclonal antibody, Carrigtwohill, 
Ireland) or Sigma-Aldrich (mouse anti-β-actin monoclonal antibody, clone AC-15, 
A1978, Dublin, Ireland). Anti-mouse and anti-rabbit IgG horseradish peroxidase 
(HRP) conjugates (Promega, Medical Supply Company, Dublin, Ireland) were 
used as secondary antibodies. Cell culture media and all other reagents were 
obtained from Sigma-Aldrich. 
 
2.2 Cell culture 
Cells were grown on 6-well and 24-well plates for Western blot experiments and 
on Petri dishes (diameter 35 mm) for patch-clamp studies. For all experiments 
requiring polarised cell monolayers (i.e., Ussing chamber measurements, 
biotinylation assays), cells were seeded on Transwell Clear filter inserts (3460, 
VWR, Dublin, Ireland) and cultured under liquid-covered culture conditions (LCC). 
The transepithelial electrical resistance (TEER) of filter-grown cell monolayers 
was measured using a Millicell ERS Volt-Ohm Meter with STX-2 chopstick 
electrodes (Millipore) and corrected for the background value contributed by the 
filter inserts and medium. The measurements were conducted every other day 
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before changing the medium. All cell lines were cultured in humidified 
atmosphere of 95% air and 5% CO2 at 37°C. 
 
2.2.1 Calu-3 cell line 
Calu-3 cells (American Type Culture Collection, ATCC HTB-55), human bronchial 
epithelial cells derived from an adenocarcinoma of the lung (by Fogh and 
Trempe, 1975), were obtained from the European Collection of Animal Cell 
Cultures (ECACC, Salisbury, UK).  
Calu-3 cells were grown in Eagle’s minimum essential medium (EMEM), 
supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin, 100 
μM/ml streptomycin, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids 
and 15 mM glucose. Cells were seeded at a density of 100,000 cells/cm2 on 
Transwell Clear inserts. A seeding density of 75,000 cells/cm2 was used for 
seeding on other cell culture plastics. 
 
2.2.2 H441 cell line 
The bronchiolar epithelial H441 cell line (American Type Culture Collection, 
ATCC HTB-174), purchased from LGC standards (Teddington, UK) was derived 
from a papillary adenocarcinoma of the lung (by Gazdar et al., 1982).  
H441 cells were cultured in RPMI-1640 Medium (Invitrogen, Biosciences, Dun 
Laoghaire, Ireland), supplemented with 10% FBS, 100 U/ml penicillin, 100 μM/ml 
streptomycin, 1 mM sodium pyruvate, 5 µg/ml insulin, 5 µg/ml human transferrin, 
5 ng/ml sodium selenite and 200 nM dexamethasone. On Transwell filter inserts, 
a seeding density of 250,000 cells/cm2 was used, otherwise 75,000 cells/cm2. 
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2.3 Stable transfection with shRNA 
Stably transfected cell lines were generated by Elena Schwagerus (Trinity 
College Dublin, Ireland). 
 
To stably down-regulate δ-ENaC expression in H441 and Calu-3 cells, 
commercially available δ-ENaC shRNA lentiviral particles (SC-42421-V, Santa 
Cruz Biotechnology) were used. The particle pool consisted of transduction-ready 
viral particles carrying three different constructs, each encoding for a 19 nt 
shRNA (shRNA sequences given in Table 1), designed to silence δ-ENaC gene 
expression, and a puromycin resistance gene. As negative control, control 
shRNA lentiviral particles (SC-108080, Santa Cruz), carrying constructs encoding 
for negative scrambled shRNA and puromycin resistance gene, were used. Cells 
(H441 passage 59, Calu-3 passage 38) were seeded at 100,000 cells/cm2 in 24-
well plates 24 h prior to lentiviral infection. The following day, medium was 
replaced by fresh medium containing 5 µg/ml Polybrene (Santa Cruz), a 
polycation, neutralising membrane charges and, hence, enhancing the interaction 
between the cell membrane and the viral capsid. Subsequently, lentiviral particles 
were added onto the cells (7.5×103 infectious units of virus (IFU) per well). Forty-
eight hours after the transduction, cells were subcultured at a 1:3 ratio. Following 
overnight incubation in complete medium, puromycin containing medium was 
applied onto the cells to select stably shRNA expressing puromycin-resistant 
cells. The puromycin concentration suitable for selection was determined 
previously as the lowest concentration to kill 100% of wild-type cells in 3-5 days 
from the start of the puromycin selection and was 2.5 µg/ml puromycin for H441 
and 7.5 µg/ml for Calu-3 cells. Subsequently, selected puromycin-resistant cells 
were expanded and, in the further course, are referred to as H441 shDENaC, 
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H441 shCTRL, Calu-3 shDENaC and Calu-3 shCTRL for H441 and Calu-3 cells 
transfected with δ-ENaC and scrambled shRNA, respectively.  
 
Table 1 
Nucleotide sequence of δ-ENaC shRNA constructs in δ-ENaC shRNA lentiviral particles (SC-
42421-V, Santa Cruz Biotechnology, Heidelberg, Germany) according to manufacturer’s product 
information. 
 
2.4 Delta-ENaC over-expression studies 
Transfections were carried out by Elena Schwagerus (Trinity College Dublin, 
Ireland). 
 
2.4.1 Transient δ-ENaC over-expression 
For transient overexpression, plasmid construct coding for human δ1-ENaC 
protein subcloned in pcDNA3.1(+) vector, kindly provided by Dr. Diego Alvarez de 
la Rosa (Universidad de La Laguna, La Laguna, Spain), was used. Details on 
shRNA 
shRNA sequence (5’ to 3’) 
Sense antisense 
A 
GUG ACG AAG CUG UGA 
UUC Att 
UGA AUC ACA GCU UCG 
UCA Ctt 
B 
CAC CUU CUU CUG CAC 
CAA Utt 
AUU GGU GCA GAA GAA 
GGU Gtt 
C 
GGU ACC ACU UCC ACU 
AUG Utt 
ACA UAG UGG AAG UGG 
UAC Ctt 
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generation and amplification of the plasmid are given below. H441 cells were 
transfected using Lipofectamine 2000 transfection reagent (Invitrogen) following 
manufacturer’s protocol. Briefly, approx 90% confluent cell monolayers were 
transfected 24 h after seeding with a transfection mixture of 0.8 µg plasmid cDNA 
and 0.4, 2 and 4 µl Lipofectamine 2000 transfection reagent (1:0.5, 1:2.5 and 1:5 
ratio of µg cDNA to µl Lipofectamine 2000) to optimise the transfection 
conditions. The Lipofectamine 2000/plasmid cDNA complexes remained on the 
cells for 24 h. Two hours after transfection, ENaC inhibitor benzamil was added 
to the medium at a concentration of 10 µM in order to prevent adverse effects of 
increased Na+ influx on cell viability. Protein samples to assess δ-ENaC over-
expression were collected 24, 48 and 72 h after transfection, quantified and 
analysed by Western blot. The transfection mixture with 1:5 ratio of µl cDNA to µl 
Lipofectamine 2000 was shown to result in the highest δ-ENaC over-expression 
levels and was used for all subsequent experiments as well as for generation of 
stably δ-ENaC over-expressing cell lines. 
 
2.4.2 Stable δ-ENaC over-expression 
H441 (passage 68) cells were transfected with a transfection mixture of 0.8 µg δ1-
ENaC plasmid cDNA and 4 µl Lipofectamine 2000. Two hours after transfection, 
10 µM benzamil was added to the medium. Cells were subcultured into medium 
containing 600 µg/ml aminoglycoside antibiotic geneticin (G418, Sigma-Aldrich) 
and 10 µM benzamil in ratio 1:5 to 1:100 forty-eight hours after transfection. A 
G418 concentration of 600 µg/ml was previously shown to be suitable for 
selection. Subsequently, several G418-resistant colonies were picked, expanded 
and assessed for δ-ENaC expression by Western blot. Colonies stably 
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expressing δ-ENaC were kept in culture and used for the subsequent expression 
and functional studies. In further course, the generated stable cell line is referred 
to as H441 DENaC.  
 
2.4.3 cDNA construct 
Plasmid construct coding for full length δ1-ENaC protein was kindly provided by 
Dr. Diego Alvarez de la Rosa (Universidad de La Laguna, La Laguna, Spain). 
Plasmid was generated, as described by Wesch et al. [59], by restriction enzyme 
subcloning of human δ1-ENaC cDNA in pcDNA3.1(+) vector, and subsequently 
amplified by transformation in Escherichia coli. Briefly, 25 µl E. coli (Invitrogen) 
were transformed with 200 ng of the relevant plasmid cDNA and, following 1 h 
incubation in 200 µl SOC medium (Invitrogen) at 37°C, plated on Luria Bertani 
(LB) plates containing 50 µg/ml ampicillin. After overnight incubation at 37°C, 5 
ml LB medium containing 50 µg/ml of ampicillin was inoculated with transformed 
E. coli and incubated for 12-16 h at 37°C with constant shaking. Subsequently, 
DNA was isolated using QIAprep Spin Miniprep Kit (Qiagen, Crawley, UK) and 
quantified with NanoDrop ND 1000 spectrophotometer (Labtech International, 
Ringmer, UK).  
 
2.5 Western blot analysis 
Unless mentioned otherwise, protein was isolated from confluent cell monolayers 
of H441 and Calu-3 cells on day 8 or 12 in culture, respectively. All steps were 
performed on ice. Cells were lysed using cell extraction buffer (Invitrogen), 
supplemented 1:100 with protease inhibitor cocktail (Sigma-Aldrich) and 
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subsequently sonicated for twice for 10 s to disrupt the cells. The lysates were 
then centrifuged for 20 min at 10,000 rpm at 4°C in order to remove the 
remaining cell debris. Supernatants were collected and used for further analysis. 
Protein concentrations were determined using a standard protein assay (Bio-Rad, 
Hemel Hempstead, UK) according to the manufacturer’s instructions. A total of 50 
μg of protein was loaded for each sample, after which samples were separated 
by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE, 
8.5% acrylamide) and transferred to immunoblot polyvinylidene fluoride 
membranes (Bio-Rad). Non-specific binding sites were blocked with 5% bovine 
serum albumin (BSA) in Tris-buffered saline (0.1% Tween 20, pH 7.4) for 1 h at 
room temperature. Incubation with the relevant primary antibody was carried out 
overnight at 4°C. Following dilutions of primary antibodies in blocking buffer were 
used: 1:250 and 1:5,000 for anti-δ-ENaC antibodies (SC and DAR, respectively); 
1:7,500 for anti-Na+/K+-ATPase, 1:8,000 for anti-β-actin. After washing with 
washing buffer (0.1% Tween 20 in Tris-buffered saline, pH 7.4), the membranes 
were incubated with the relevant HRP-conjugated secondary antibodies at the 
dilution 1:12,500 for 1 h at room temperature. Peroxidase activity was detected 
with Immobilon Western Chemiluminescent HRP substrate (Millipore). Using a 
Chemidoc documentation system (Bio-Rad), relative levels of protein expression 
were quantified by densitometric analysis of the immunoblot and normalisation to 
β-actin to ensure equal loading. 
 
2.6 Cell surface biotinylation 
Cells were grown on Transwell Clear inserts and used on day 8 (H441) or day 12 
(Calu-3) in culture. All steps were performed on ice, using ice-cold solutions. 
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After both apical and basolateral sides of cell monolayers were rinsed with PBS 
containing 2.0 mM CaCl2, 0.5 ml or 1.5 ml of biotinylation solution (0.5 mg/ml 
sulpho-NHS-biotin, 85 mM NaCl, 4 mM KCl, 15 mM Na2B4O7, pH 9.0) were 
added to the apical or basolateral compartments, respectively. Phosphate 
buffered saline, supplemented with 2.0 mM CaCl2 and 10% BSA, was applied to 
the respective opposite compartments, and cell monolayers were incubated with 
gentle agitation for 20 min at 4°C. A second 20 min incubation with 10% BSA in 
PBS, added to both compartments, followed to stop the biotinylation reaction. 
Subsequently, cells were treated with biotinylation lysis buffer (0.4% 
deoxycholate, 1% Triton X-100, 50 mM EGTA, 10 mM Tris-HCl, pH 7.4), 
supplemented with protease inhibitor cocktail (Sigma-Aldrich). To isolate the 
biotinylated membrane proteins, whole cell lysates were added to streptavidin-
agarose beads (Sigma-Aldrich) and incubated overnight at 4°C. The following 
day, biotinylated proteins, now bound onto the beads, were separated from non-
biotinylated proteins by centrifugation and extensive washing. Subsequently, 
biotinylated proteins were eluted by incubating the beads in 2x loading buffer at 
room temperature and at 95°C for 20 and 5 min, respectively. Apical and 
basolateral membrane proteins were then analysed by Western blot. 
 
2.7 Protein deglycosylation 
GlycoProfile II, Enzymatic In-Solution N-Deglycosylation kit (Sigma-Aldrich) was 
used according to manufacturer’s instructions. Briefly, sample aliquot containing 
50 µg protein was diluted to the total volume of 90 µl and denaturised by 
incubation with denaturant solution containing 2% octyl-β-D-glucopyranoside and 
100 mM β-mercaptoethanol at 100°C for 10 min. Samples were then divided into 
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two aliquots. PNGase F Enzyme Solution was added to the test sample at the 
concentration of 50 units/ml. Equal volume of water was added to the untreated 
control sample. After 5 hours of incubation at 37°C, the reaction was stopped by 
heating at 100°C for 10 min. 
PNGase F treated samples and untreated controls were subsequently analysed 
by Western blot. 
 
2.8 Immunofluorescence microscopy (IFM) 
Transwell filter grown cell monolayers were fixed by 10 min incubation with ice-
cold methanol, followed by 8 min permeabilisation with 0.1% Triton X-100. 
Unspecific binding sites were blocked by incubation with PBS containing 5% BSA 
at 37°C for 30 min. After a 60 min incubation with 200 μl dilution of the respective 
primary antibody (δ-ENaC (SC), δ-ENaC (DAR) 1:50) in PBS containing 1% BSA, 
the cell layers were washed three times with PBS (1% BSA), before incubation 
with 200 μl of a 1:1000 dilution of the relevant Alexa Fluor-488-labelled F(ab')2 
fragment in PBS containing 1% BSA. To counterstain cell nuclei, propidium 
iodide (1 μg/ml in PBS) was used. After 30 min of incubation, the specimens were 
again washed three times with PBS (1% BSA) and embedded in FluorSave anti-
fade medium (Merck, Nottingham, UK). Images were obtained using a confocal 
laser scanning microscope (CLSM, Zeiss LSM 510, Göttingen, Germany). 
 
2.9 Ussing chamber experiments 
Confluent cell monolayers grown on Transwell Clear filter inserts were mounted 
in custom-made, modified Ussing chambers. Both chamber compartments were 
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filled with Krebs-Ringer-Buffer pH 7.4 (116.4 mM NaCl, 5.4 mM KCl, 0.78 mM 
NaH2PO4, 25 mM NaHCO3, 5.55 mM glucose, 15 mM HEPES, 1.8 mM CaCl2, 
0.81 mM MgSO4). For a number of experiments with wild-type H441 cells, 
sodium-free KCl-Ringer-Buffer was also used (5.4 mM NaCl, 116.4 mM KCl, 0.78 
mM KH2PO4, 25 mM KHCO3, 1.8 mM CaCl2 , 0.81 MgSO4, 5.55 mM glucose, 15 
mM HEPES). Bathing solutions were continuously stirred and maintained at 37°C 
throughout the experiment. 
For detection of electrical parameters, Ag/AgCl electrodes with KCl/agar bridges 
(3% agarose in 3 M KCl) were used to connect the chamber with the voltage-
clamp amplifier. The transepithelial potential difference (Vt) was clamped to 0.0 
mV and the short-circuit current (ISC) was measured with DVC-1000 Dual voltage 
Clamp (World Precision Instruments, Sarasota, FL). To monitor the transepithelial 
electrical resistance, voltage pulses of 0.5 mV were applied for duration of 5 s 
every 50 s. The ISC was continuously recorded using Chart5 for Windows 
software (ADInstruments, Oxfordshire, UK). 
After a stable basal ISC was reached (after approximately 10-15 min), chemical 
compounds were applied. Stock solutions of 50 mM Evans blue, 5 mM 
capsazepine, 10 mM icilin, 50 mM amiloride and 100 mM ouabain, all dissolved 
in DMSO, were used (all from Sigma-Aldrich). 
Ussing chamber studies with Calu-3 monolayers, wild-type as well as 
transfectants, were carried out between day 14 and 21 in culture (Calu-3: 
passage 39, 45, 47; Calu-3 shCTRL: passage 46, 48, 59; Calu-3 shDENAC: 
passage 47, 48, 60). H441 cells were used on day 8 to 14 in culture (H441: 
passage 63 – 65; H441 shCTRL: passage 67, 69, 70; H441 shDENAC: passage 
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67, 69, 70; H441 DENaC: passage (+8) – (+12)). Cell monolayers were only used 
if the transepithelial electrical resistance reached a value of at least 400 Ω•cm2. 
 
2.10 Patch-clamp recordings 
Patch-clamp studies were performed using δ-ENaC over-expressing H441 cells 
in the whole-cell configuration (passages (+8) – (+12)). Cells were seeded on 
Petri-dishes (diameter 35 mm) in H441 cell culture medium containing 600 μg/ml 
G418 and 10 μM benzamil 24 h prior to the experiments.  
 
 Bath solution Pipette Solution 
NaCl 140 - 
CsCl - 140 
CaCl2 2 - 
MgCl2 1 1 
EGTA - 5 
HEPES 10 10 
Table 2 
Patch-clamp solutions (concentrations in mM). 
 
Borosilicate glass capillaries (Harvard Apparatus, Edenbridge, UK) were pulled to 
patch electrodes (2–4 MΩ resistance) using a DMZ-universal-puller (Zeitz-
Instruments, Munich, Germany) and back-filled with pipette solution (pH 7.4; 280 
mOsm/kg H2O). Cells were first rinsed and then continuously perfused with bath 
solution (pH 7.4; 300-310 mOsm/kg H2O) (Table 2).  
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After selecting a cell for recording, the pipette was introduced into the bath 
solution, and the current offset was adjusted to zero. By gently pressing the 
pipette against the cell surface and applying slight negative pressure, a seal of 
more than 10 GΩ resistance was formed. Steadily increased suction was applied 
to break into the whole-cell mode. The access resistance was kept as low as 
possible (Ra < 15 MΩ). The holding potential was clamped to -60 mV. Currents 
were amplified with Axopatch 200B amplifier, sampled at 2 kHz using Digidata 
1322A and recorded using Clampex software (all from Axon instruments, Jakarta, 
Indonesia). Data analysis was carried out using Clampfit 9.2 software (Axon 
instruments). 
After the currents in whole cell mode stabilised, 10 µM amiloride were added to 
determine the portion of amiloride-sensitive (and α-ENaC-mediated) current. 
Subsequently, cells were perfused with bath solution to reverse the inhibition by 
amiloride, and 20 µM capsazepine were added. Finally, cells were perfused with 
the bathing solution containing both 10 µM amiloride and 20 µM capsazepine in 
order to evaluate the percentage of amiloride-sensitive currents off the 
capsazepine-induced effect. 
 
2.11 Statistical analysis 
Each experiment was carried out at least in triplicate using cells from different 
passages and results were expressed as means ± SD unless mentioned 
otherwise. Two groups were compared using one-way analysis of variance 
(ANOVA), followed by the Student–Newman–Keuls post-hoc test. P < 0.05 was 
considered as significant. 
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3 RESULTS 
3.1 Sodium-dependence of the pharmacological responses to 
the alleged δ-ENaC modulators in H441 cells 
A side project of this thesis was concerned with determining the sodium-
dependence of effects caused by the respective activators and inhibitors of δ-
ENaC function in H441 cells. To this end, Ussing chamber experiments were 
carried out in KRB and also in the corresponding sodium-free buffer.  
To estimate the integrity of the cell monolayer, the transepithelial electrical 
resistance (TEER) values of cells grown on permeable filter supports were 
measured every other day. Only monolayers with resistances exceeding 400 
Ω•cm2 were used for Ussing chamber studies. H441 cells grown on Transwell 
Clear inserts developed TEER values > 400 Ω•cm2 by day 6 in culture (Figure 7).  
 
The average basal ISC was 4.7 ± 1.4 µA/cm2 (n = 10) in KRB. In sodium-free 
buffer, cell monolayers displayed initial ISC values of 0.2 ± 0.7 µA/cm2 (n = 10).  
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Figure 7 
Transepithelial electrical resistances of H441 wt (passage 61) cell monolayers grown on 
permeable filter inserts in course of the time in culture. Red dotted line symbolises TEER of 
400 Ω•cm2. Results are expressed as means ± SD (n = 6). 
 
 
Figure 8 presents representative current traces of H441 wt cells in response to 
administration of Evans blue (EB), capsazepine and icilin in KRB and sodium-free 
buffer, respectively. 
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Figure 8 
Sodium-dependence of the apical responses to EB, capsazepine and icilin in H441 cell 
monolayers. Comparison of the representative current traces, obtained after application of 
100 µM and 300 µM EB (A), 20 µM capsazepine (B) and 60 µM icilin (C) to the H441 cell 
monolayers in KRB (black line) and in sodium-free buffer (red line).  
 
 
In the absence of sodium, adding 100 µM EB to the H441 cell monolayers had an 
effect of 0.02 ± 0.18 µA/cm2 (n = 4). Addition of 300 µM EB resulted in a change 
of the ISC of -0.07 ± 0.30 µA/cm2 (n = 4). The change in ISC in both cases was 
negligible and significantly different from the effect in KRB (i.e., 100 µM EB: -2.3 
± 1.2 µA/cm2; 300 µM EB: -3.3 ± 1.3 µA/cm2) (P < 0.01) (Figure 9). 
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When applied apically, 20 µM capsazepine resulted in a decrease in ISC of 0.04 ± 
0.06 µA/cm2 (n = 3). In contrast, the ISC decrease in KRB accounted for 1.0 ± 0.8 
µA/cm2 (n = 3). However, due to the high standard deviation, the difference in the 
amplitudes of the capsazepine-effects in KRB and sodium-free medium was not 
significant. 
 
The application of 60 µM icilin in the absence of sodium ions led to the most 
pronounced effect, compared to the effects of EB and capsazepine in the 
sodium-free buffer. Short-circuit currents were decreased by 0.17 ± 0.15 µA/cm2 
(n = 3). Nevertheless, the amplitude of the decrease was significantly smaller 
than in KRB (1.1 ± 0.4) (P < 0.05). 
 
In summary, effects observed in sodium-free buffer did not represent significant 
changes of ISC compared to the baseline level. In contrast, in KRB, addition of 
Evans blue, capsazepine and icilin affected the short-circuit currents across H441 
cell monolayers significantly. Figure 9 demonstrates the differences in the effects 
observed in KRB and in sodium-free buffer. 
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Figure 9 
Sodium-dependence of apical response to 100 μM and 300 μM Evans blue, 20 μM 
capsazepine and 60 μM icilin in H441 cell monolayers. Results are expressed as means ± 
SD (n = 3-4). The statistical significance of the difference is expressed as **, P < 0.01 and *, 
P < 0.05 versus the compounds’ effects in sodium-free buffer. 
 
 
3.2 Stable knock-down of the δ-ENaC subunit in H441 and Calu-
3 cells using shRNA 
The effects of the δ-ENaC modulators had previously been investigated in Dr. 
Ehrhardt’s lab. Since they were different from published data [21, 47, 54, 58], my 
aim was to determine the δ-ENaC specificity of the observed effects by knocking-
down the δ-ENaC protein.  
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3.2.1 Western blot studies – monitoring changes in the δ-ENaC expression 
on protein level 
For the densitometric quantification, the bands at 100 kDa and 70 kDa were 
analysed. Beta-actin was used as loading control. 
 
3.2.1.1 H441 
When incubated with the SC antibody, H441 immunoblots revealed a prominent 
band above 70 kDa, resembling the calculated molecular weight of the δ-ENaC 
protein, a much fainter band at 100 kDa, corresponding to the δ-ENaC protein 
according to the manufacturer’s specifications, as well as multiple protein bands 
at lower molecular weights (Figure 10 (A)). 
 
Figure 10 
(A) Western blot of lysates from H441 wild-type, shCTRL and shDENAC cells, probed with 
anti-δ-ENaC SC antibody (3 lanes represent protein isolations from 3 different passages) 
(B) Densitometric analysis of δ-ENaC protein bands detected at 70 and 100 kDa relative to 
β-actin (means ± SD, n = 3). *, P < 0.05 vs. relative signal intensity of the respective bands 
in the wild-type cells. 
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The densitometric quantification of protein band intensities at both 70 kDa and 
100 kDa (Figure 10 (B)) suggested a significant decrease in δ-ENaC abundance 
in mock-transfected H441 cells (H441 shCTRL), when compared to the 
expression levels in the wild-type cells. However, no significant decrease was 
observed in δ-ENaC knockdown transfectants (H441 shDENAC). It was rather 
the case that H441 shDENaC transfectants showed higher δ-ENaC expression 
than the H441 shCTRL cells. This observation could potentially be explained by 
incomplete blotting of the mock-transfected samples, as seen in Figure 10 (A). 
 
In contrast, in Western blots incubated with DAR antibody distinctive bands at 
100 kDa, but only very faint bands at 70 kDa (Figure 11 A) were observed. 
 
Figure 11 
(A) Western blot of lysates from H441 wild-type, shCTRL and shDENAC cells, probed with 
anti-δ-ENaC DAR antibody (3 lanes represent protein isolations from 3 different passages). 
(B) Densitometric analysis of δ-ENaC protein bands detected at 70 and 100 kDa relative to 
β-actin (means ± SD, n = 3). #, P < 0.05 vs. relative signal intensity of the respective bands 
in the wild-type cells; * P < 0.01 vs. H441 shCTRL cells. 
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As presented in Figure 11 (B), there was a significant decrease in the intensity of 
the 100 kDa band in H441 shCTRL, when compared to H441 wt samples. 
However, a significant increase in the band intensity was observed at 70 kDa, 
when shCTRL samples were compared to both wild-type and shDENaC H441 
samples. Again, these significant differences are more likely to be due to 
insufficient blotting rather than to a decrease in protein expression levels.  
Densitometric analysis did not indicate a significant decrease in the protein 
expression of δ-ENaC in H441 shDENAC cells compared to the wild-type H441 
cells, regardless of the antibody used and the molecular weight of the band 
analysed.  
 
3.2.1.2 Calu-3 
In respect of protein band patterns as well as of signal intensities detected at 70 
kDa and 100 kDa, immunoblots of Calu-3 cell lysates were similar to those of 
H441 cells, obtained with both SC and DAR antibodies (Figure 12 (A/C)). 
Using SC antibody, no significant differences in δ-ENaC protein expression were 
observed in Calu-3 shDENAC cells compared to the wild-type, at either of the 
molecular weights analysed (70 kDa and 100 kDa) (Figure 12 (B)). 
Figure 12 (D) indicates significant increases of band intensities at 100 kDa (Calu-
3 shCTRL) and at 70 kDa (Calu-3 shDENAC) compared to the respective signals 
in the wild-type cells. However, no reduction of protein expression in δ-ENaC 
shRNA transfected Calu-3 cells (shDENaC) was detected. 
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Figure 12 
Western blot of cell lysates from Calu-3 wt, Calu-3 shCTRL and Calu-3 shDENAC cells, 
probed with anti-δ-ENaC SC (A) and DAR (C) antibodies (3 lanes represent protein 
isolations from 3 different passages). Densitometric analysis of δ-ENaC protein bands, 
detected at 70 and 100 kDa using SC and DAR antibodies ((B) and (D), respectively), 
relative to β-actin (means ± SD, n = 3). *, P < 0.01 vs. relative signal intensity of the 
respective bands in the wild-type cells. 
 
 
3.2.2 Ussing chamber studies – monitoring the knock-down of δ-ENaC 
expression on the functional level 
After mounting cell monolayers grown on Transwell filter inserts into the Ussing 
chambers and stabilisation of the ISC, Evans blue, capsazepine and icilin were 
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applied apically to the cell monolayers. In the cells stably transfected with δ-
ENaC shRNA, the responses to the administration of the compounds were 
expected to be of smaller amplitude than in the wild-type and mock-transfected 
cells, due to down-regulated δ-ENaC expression levels, under assumption that 
the effects were δ-ENaC-specific and δ-ENaC knock-down was sufficient. The 
responses in the wild-type and mock-transfected cells were expected to be of 
comparable amplitudes. 
 
3.2.2.1 Calu-3 
Calu-3 cells grown on Transwell Clear inserts developed TEER values > 400 
Ω•cm2 by day 5-6 in culture, as shown in Figure 13, and were used on days 14 to 
21, when TEER values peaked. There was no relevant difference in TEER values 
between Calu-3 wt, Calu-3 shCTRL and Calu-3 shDENAC cells. 
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Figure 13 
Transepithelial electrical resistances of Calu-3 wt (passage 45), Calu-3 shCTRL (passage 
46) and Calu-3 shDENAC (passage 48) cell monolayers grown on permeable filter inserts in 
course of the time in culture. Red dotted line symbolises TEER of 400 Ω•cm2. Results are 
expressed as means ± SD (n = 6). 
 
 
Before adding the respective compound to the cell monolayers, the baseline 
short-circuit current value (ISC) was given time (~10 min) to stabilise. The average 
steady state baseline ISC was determined for Calu-3 wt, Calu-3 shCTRL and 
Calu-3 shDENAC cells and did not differ significantly between the cell types 
(Figure 14).  
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Figure 14 
Steady state short-circuit current values (basal ISC [μA]) of Calu-3 wt, Calu-3 shCTRL and 
Calu-3 shDENAC cell monolayers, obtained under standard conditions (apical and 
basolateral KRB; pH = 7.4) prior to the start of the measurements. Results are expressed as 
means ± SD (n = 10). 
 
 
Response to apical application of Evans blue 
Despite the fact that Evans blue (EB) has been stated to be a selective 
antagonist of δ-ENaC [47], it increased the ISC levels in Calu-3 cell monolayers. 
Figure 15 (A) shows typical ISC traces obtained in Calu-3 wild-type (black graph), 
Calu-3 shCTRL (red graph) and Calu-3 shDENAC (blue graph) cells after 
administration of 100 μM and 300 μM EB.  
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Figure 15 
(A) Overlay of the representative current traces obtained in response to 100 μM and 300 
μM Evans blue in the wild-type (wt, black line) and mock-transfected (shCTRL, red line) 
Calu-3 cells as well as in the cells transfected with δ-ENaC shRNA (shDENAC, blue line). 
(B) Effects of apically administered Evans blue in Calu-3 wt, shCTRL and shDENAC cells. 
Short-circuit current values were measured 10 min after adding 100 and 300 μM of Evans 
blue and normalised to the baseline ISC (100%). Results are expressed as means ± SD (n = 
3 - 4). *, P < 0.05 vs. baseline; **, P < 0.01 vs. baseline. 
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Apical administration of 100 µM EB increased the ISC of Calu-3 wild-type cell 
monolayers by 103.8 ± 28.5% (n = 4). Increases by 131.1 ± 47.4% (n = 3) and 
137.9 ± 31.0% (n = 4) were observed in Calu-3 shCTRL and Calu-3 shDENAC 
cells, respectively (Figure 15 (B)). In all cases, the resulting ISC levels were 
significantly different from the baseline (P < 0.01). 
There was an additional significant increase in the ISC resulting from the 
application of 300 µM EB, i.e., by 264.7 ± 109.7% of the baseline level in Calu-3 
wt (n = 4; P < 0.01), by 300.0 ± 172.6% in Calu-3 shCTRL (n = 3; P < 0.05) and 
by 287.9 ± 108.7% in Calu-3 shDENAC cells (n = 3; P < 0.01). Hence, short-
circuit current stimulation by EB was concentration-dependent in all cell types. 
 
Response to apical application of capsazepine 
Interestingly, the selective activator of δ-ENaC function, capsazepine [54], did not 
increase the ISC, but to the contrary had an inhibitory effect on the currents in 
Calu-3 cells, as shown in Figure 16 (A).  
Whilst the ISC decrease was significant in Calu-3 wt cells (14.7 ± 1.7% of the 
basal ISC; n = 4; P < 0.01), currents were also inhibited in the mock-transfected 
and δ-ENaC shRNA transfected cells, however, not significantly due to a small 
number of replicates and a rather high standard deviation (n = 4) (Figure 16 (B)).  
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Figure 16 
 (A) Overlay of the current traces in response to addition of 20 μM capsazepine, obtained 
during representative Ussing chamber experiments in Calu-3 wild-type (black line), Calu-3 
shCTRL (red line) and Calu-3 shDENAC cells (blue line).  
(B) Effects of apically administered capsazepine (20 μM) in Calu-3 wt, shCTRL and 
shDENAC cells. Short-circuit current values were measured 10 min after adding the 
compound and normalised to the baseline ISC (100%). Results are expressed as means ± 
SD (n = 4). *, P < 0.01 vs. baseline. 
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Response to apical application of icilin 
Icilin has been described to be a selective activator of δ-ENAC function [58]. 
Indeed, the compound stimulated currents across the monolayers of Calu-3 wt 
cells as well as of the respective control- and knock-down-transfectants (Figure 
17 (A)).  
Administration of 60 μM icilin led to significant increases in the ISC in Calu-3 wt 
and in Calu-3 shDENAC cells, by 47.6 ± 8.8% (n = 3) and 47.6 ± 12.2% (n = 5) of 
the baseline level, respectively. In Calu-3 shCTRL cells, the increase by 64.2 ± 
53.1% (n = 4) was not significant due to the high standard deviation (Figure 17 
(B)).  
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Figure 17 
(A) Overlay of the representative current traces obtained in response to 60 μM icilin in Calu-
3 wild type (black line), Calu-3 shCTRL (red line) and Calu-3 shDENAC cells (blue line). 
(B) Effects of apically administered icilin (60 μM) in Calu-3 wt, shCTRL and shDENaC cell 
monolayers. Short-circuit current values were measured 10 min after adding the compound 
and normalised to the baseline ISC (100%). Results are expressed as means ± SD (n = 3 - 
5). *, P < 0.01 vs. baseline. 
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Comparison of the effects exhibited by the alleged modulators of δ-ENaC 
function in the wild-type, mock-transfected as well as in δ-ENaC shRNA 
transfected Calu-3 cells  
Figure 18 summarises and compares the effects induced by Evans blue, 
capsazepine and icilin on the short-circuit currents in the wild-type (wt), mock-
transfected (shCTRL) as well as δ-ENaC shRNA transfected (shDENAC) Calu-3 
cells.  
No significant difference in effects was observed between the mock-transfected 
Calu-3 shCTRL and Calu-3 shDENAC cells, suggesting that higher amplitude of 
the ISC activation by EB in Calu-3 shCTRL and shDENAC cells could be due to 
the transfection procedure as such, rather than to down-regulation of δ-ENaC. 
The observed inhibitory effects in response to administration of capsazepine did 
not differ significantly between the non-transfected Calu-3 cells and both 
transfectant types. Similarly, no significant difference in icilin-induced current 
activation was observed between Calu-3 wt, shCTRL and shDENaC cells. 
In summary, no significant differences in pharmacological responses to 
administration of either of the compounds were detected between the wild-type, 
mock-transfected and δ-ENaC shRNA transfected Calu-3 cells.  
 
43 
 
Figure 18 
Quantification of responses to 100 μM and 300 μM Evans blue, 20 μM capsazepine and 60 
μM icilin in Calu-3 cell monolayers of non-transfected cells (wt) as well as of cells, stably 
transfected with scrambled shRNA (shCTRL) and shRNA, designed to silence δ-ENaC 
(shDENAC). Short-circuit currents values, measured after the administration of the relevant 
compound, were normalised to the basal ISC. Results are expressed as means ± SD (n = 3). 
 
 
3.2.2.2 H441 
As shown in Figure 19, H441 cells reached TEER values over 400 Ω•cm2 by day 
6 in culture. Transfected cells required approximately 9 days until they reached 
TEER levels > 400 Ω•cm2. H441 cells were used for Ussing chamber 
experiments between day 7 and day 14 in culture when TEER values peaked. 
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Figure 19 
Transepithelial electrical resistance of H441 wt (passage 61), H441 shCTRL (passage 67) 
and H441 shDENAC (passage 67) cell monolayers grown on permeable filter inserts in 
course of the time in culture. Red dotted line symbolises TEER of 400 Ω•cm2. Results are 
expressed as means ± SD (n = 6).  
 
 
The basal ISC of H441 wt monolayers stabilised on an average level of 4.2 ± 1.2 
µA (n = 10), whereas the basal ISC of H441 shCTRL and H441 shDENAC 
monolayers were significantly higher (7.8 ± 2.8 µA and 9.6 ± 5.7 µA, respectively; 
n = 10; P < 0.01) (Figure 20). However, there was no significant difference 
between the baseline ISC levels of H441 shCTRL and H441 shDENAC cells.  
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Figure 20 
Steady state short-circuit current values (basal ISC [μA]) of H441 wt, H441 shCTRL and 
H441 shDENAC cell monolayers, obtained under standard conditions (apical and 
basolateral KRB; pH = 7.4) prior to the start of the measurements. Results are expressed as 
means ± SD (n = 10). **, P < 0.01 vs. basal ISC of the wild-type cells. 
 
 
Response to apical application of Evans blue 
Evans blue, which has been suggested as a selective δ-ENaC antagonist [47], 
decreased the ISC of H441 cells in a concentration-dependent manner. Figure 21 
(A) shows typical ISC traces of H441 wild type (black line), H441 shCTRL (red 
line) and H441 shDENAC (blue line) cells in response to the administration of 100 
μM and 300 μM of Evans blue. 
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Figure 21 
(A) Overlay of the representative current traces obtained in response to 100 μM and 300 
μM Evans blue in the wild-type (wt, black line) and mock-transfected (shCTRL, red line) 
H441 cells as well as in the cells transfected with δ-ENaC shRNA (shDENAC, blue line). 
(B) Effects of apically administered Evans blue in H441 wt, shCTRL and shDENAC cells. 
Short-circuit current values were measured 10 min after adding 100 and 300 μM of Evans 
blue and normalised to the baseline ISC (100%). Results are expressed as means ± SD (n = 
4). *, P < 0.01 vs. baseline. 
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More precisely (Figure 21 (B)), application of 100 μM Evans blue led to a 
significant decrease in the ISC in H441 wt and H441 shCTRL cells, by 47.4 ± 
11.0% and 46.2 ± 2.9% of the basal ISC (n = 4; P < 0.01), respectively. After 
administration of 300 μM Evans blue, a further significant reduction of ISC was 
observed, with the resulting ISC accounting for 26.0 ± 11.5% and 18.6 ± 12.1% of 
the baseline short-circuit current, respectively (n = 4; P < 0.01). The highest 
decrease in ISC of 69.2 ± 5.4% after administration of 100 μM Evans blue was 
observed in H441 shDENAC cells. However, treatment with 300 μM Evans blue 
did not decreased the ISC further, with the resulting ISC being 67.1 ± 18.3% of the 
initial baseline level (n = 4; P < 0.01 vs. baseline). 
 
Response to apical application of capsazepine 
The selective activator of δ-ENaC function, capsazepine, did not increase the ISC 
in H441 cells, but instead lead to a significant decrease. This effect was observed 
in the H441 wild-type as well as in the both transfected cell types.  
 
As shown in Figure 22, there was a significant drop in the ISC after administration 
of 20 μM capsazepine. The compound inhibited the currents in H441 wt 
monolayers by 25.3 ± 15.2% (n = 3; P < 0.05). In H441 shCTRL and H441 
shDENAC cells, currents were inhibited by 28.4 ± 6.8% (n = 3; P < 0.01) and 22.4 
± 13.6% (n = 3; P < 0.05), respectively.  
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Figure 22 
(A) Overlay of the current traces in response to addition of 20 μM capsazepine, obtained 
during representative Ussing chamber experiments in H441 wild-type (black line), H441 
shCTRL (red line) and H441 shDENAC cells (blue line). 
(B) Effects of apically administered capsazepine (20 μM) in H441 wt, shCTRL and 
shDENAC cells. Short-circuit current values were measured 10 min after adding the 
compound and normalised to the baseline ISC (100%). Results are expressed as means ± 
SD (n = 3). *, P < 0.05 vs. baseline; **, P < 0.01 vs. baseline. 
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Response to apical application of icilin 
Despite the fact that icilin was reported to be a selective δ-ENaC activator [58], 
administration of 60 μM icilin resulted in a significant inhibition of sodium currents 
in H441 cells (Figure 23 (B)). 
The ISC of H441 wt decreased to 72.3 ± 16.0% of the initial short-circuit current 
level (n = 3; P < 0.05). In H441 shCTRL and H441 shDENaC cells, icilin caused a 
smaller decrease of the ISC, i.e., 11.7 ± 6.0% (n = 3; P < 0.05) and 12.9 ± 4.2% (n 
= 3; P < 0.01). 
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Figure 23 
(A) Overlay of the representative current traces obtained in response to 60 μM icilin in H441 
wild-type (black line), H441 shCTRL (red line) and H441 shDENAC cells (blue line). 
(B) Effects of apically administered icilin (60 μM) in H441 wt, shCTRL and shDENaC cell 
monolayers. Short-circuit current values were measured 10 min after adding the compound 
and normalised to the baseline ISC (100%). Results are expressed as means ± SD (n = 3). *, 
P < 0.05 vs. baseline; **, P < 0.01 vs. baseline. 
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Comparison of the effects exhibited by the alleged modulators of δ-ENaC 
function in the wild-type cells, mock-transfected as well as in δ-ENaC shRNA 
transfected H441 cells 
Figure 24 compares the effects induced by the administration of Evans blue, 
capsazepine und icilin in the wild-type (wt) H441 cells to the effects observed in 
the mock-transfected (shCTRL) and δ-ENaC shRNA transfected (shDENAC) 
H441 cells. 
All compounds tested entailed inhibitory effects in H441 wt, H441 shCTRL and 
H441 shDENaC cell monolayers, although different outcomes, at least for 
capsazepine and icilin, were reported by other research groups [47, 54, 58].  
On the one hand, only the effects induced by 100 μM Evans blue were 
significantly different in their amplitude between H441 shDENaC and H441 wt (P 
< 0.05) as well as between H441 shDENaC and H441 shCTRL (P < 0.01) cells. 
However, in contrast to our expectations, the remaining ISC was significantly 
lower and, therefore, EB-effect was more pronounced in H441 shDENAC 
monolayers than H441 wt or H441 shCTRL. On the other hand, after application 
of either 300 μM EB, 20 μM capsazepine or 60 μM icilin, H441 shDENAC cells 
displayed higher ISC levels compared to H441 wt cells. This suggests that the 
respective effects were less pronounced in the δ-ENaC shRNA transfected cells. 
These differences, however, were not significant.  
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Figure 24 
Quantification of responses to 100 μM and 300 μM Evans blue, 20 μM capsazepine and 60 
μM icilin in H441 cell monolayers of non-transfected cells (wt) as well as of cells, stably 
transfected with scrambled shRNA (shCTRL) and shRNA, designed to silence δ-ENaC 
(shDENAC). Short-circuit currents values, measured after the administration of the relevant 
compound, were normalised to the basal ISC. Results are expressed as means ± SD (n = 3-
4). The statistical significance of the effects versus H441 shCTRL is expressed as *, P < 
0.01 and versus H441 wild-type as #, P < 0.05. 
 
Hence, it can be summarised that no significant differences in pharmacological 
responses to administration of either of the compounds were detected between 
the wild-type, mock-transfected and δ-ENaC shRNA transfected H441 cells. 
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3.3 Stable δ-ENaC over-expression in H441 cells 
Due to the fact that previous RNAi results proved to be inconclusive a different 
approach, i.e., δ-ENaC over-expression, was used to investigate the specificity of 
the observed effects of the δ-ENaC modulators. 
  
3.3.1 Analysis of δ-ENaC over-expression in H441 cells by means of 
Western blot 
Figure 25 shows protein samples from 5 different stably transfected colonies 
probed with anti-δ-ENaC antibody (DAR) and compared to a negative control 
sample (n), i.e., lysate of H441 wild-type cells, as well as a positive control 
sample (p), i.e., lysate of H441 cells transiently transfected with δ-ENaC plasmid. 
There was no difference between the seven lanes regarding the 100 kDa protein 
band. However, as shown in Figure 25, differences in the band intensities of the 
70 kDa band were observed between the lanes. In the negative control sample, 
only a faint band was detected at 70 kDa, whereas in the positive control a 
prominent 70 kDa band was present. Only in one of the stably transfected H441 
clones (lane 4), a similarly prominent band at 70 kDa was detected. Furthermore, 
a second band, at around 65 kDa, was observed in sample 4. It can be 
speculated that this band represents a deglycoslylated form of the full-length δ1-
ENaC protein. As for the other samples (lanes 1-3, 5), they resembled the 
negative control, with solely a faint band appearing at 70 kDa. Hence, only clone 
4 showed stable over-expression of δ-ENaC protein. This clone was expanded, 
and cells deriving thereof were used for all the subsequent experiments. 
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Figure 25 
Western blot of δ1-ENaC protein over-expression. Human bronchiolar H441 cells were 
transfected with δ1-ENaC plasmid, integrated into pcDNA3.1(+) vector, and exposed to 
geneticin for selection. Subsequently, protein was isolated from different geneticin-resistant 
H441 colonies (Lane 1-5) and analysed by Western blot using anti-δ-ENaC antibody (DAR). 
n = negative control: wild-type H441 cells. p = positive control: H441 cells transiently 
transfected with δ1-ENaC plasmid. Beta-actin was used as loading control.  
 
 
Further, localisation of the over-expressed δ-ENaC protein was studied. 
Biotinylation experiments were carried out in order to separate cell surface 
protein from the intracellularly localised protein. The apical and the basolateral 
cell membranes were labelled with biotin as described previously. Biotinylated 
cell surface protein was isolated and analysed by Western blot using anti-δ-ENaC 
antibody (DAR) (Figure 26). Na+/K+-ATPase served as a control to test for 
100 kDa
70 kDa
β-actin
n p 1 5432
H441 stably transfected and
geneticin (G418) resistant
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potential contamination of the apically biotinylated protein samples with 
basolateral proteins. In addition, β-actin was used as a control for contamination 
of the biotinylated membrane protein fractions with intracellular proteins. 
 
 
Figure 26 
Representative Western blot of whole cell lysate (wc) as well as of apically (ap) and 
basolaterally (bas) biotinylated surface protein fractions of δ-ENaC over-expressing H441 
cells obtained with DAR polyclonal anti-δ-ENaC antibody. Beta-actin and Na+/K+-ATPase 
were used as controls for potential contamination of the biotinylated samples with 
intracellular and basolateral protein, respectively. 
 
The first protein lane in Figure 26 represents the whole cell lysate of the stably 
transfected, δ-ENaC over-expressing H441 cells. Here, a protein band at 100 
kDa as well as two δ-ENaC-specific bands at 70 and 65 kDa were detected using 
anti-δ-ENaC antibody (DAR). Also, Na+/K+-ATPase and β-actin were detected in 
100 kDa
70 kDa
β-actin
Na+/K+-ATPase
basapwc
H441 DENaC
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the whole cell lysate. In the apically biotinylated sample, a faint band at 70 kDa 
was detected, however, no band at 65 kDa was observed. In contrast, a 
distinctive band at 70 kDa and a faint band at 65 kDa were detected in the 
basolaterally biotinylated sample. Βeta-actin was absent from both apical and 
basolateral samples, indicating that the membrane samples were not 
contaminated with intracellular contents. Na+/K+-ATPase, which is located in the 
basolateral membrane of epithelial cells, was not detected in either of the 
biotinylated samples. 
 
Glycosylation of proteins, in particular, O-linked and N-linked addition of glycans 
to certain amino acids residues, is an important post-translational modification in 
eukaryotic cells. In order to test whether the distinctive band at 70 kDa represents 
the glycosylated form of the protein detected at a slightly lower molecular weight 
(65 kDa), protein sample was treated with PNGase F, a glycoaminidase that 
cleaves the link between asparagine and N-acetylglucosamine. 
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Figure 27 
Glycosylation state of δ1-ENaC, over-expressed in H441 cells. Protein was isolated from δ1-
ENaC over-expressing H441 cells, deglycosylated by treatment with PNGase F and 
analysed by Western blot using anti-δ-ENaC antibody (DAR). Untreated protein sample was 
run in parallel. Beta-actin was used as loading control. 
 
Figure 27 shows Western blot analysis of the untreated, negative control sample 
(labelled H441 DENaC -PNGase) and of a protein sample treated with the 
deglycosylation enzyme (H441 DENaC + PNGase).  
The 100 kDa protein band was present in both samples. However, in the PNGase 
F treated sample, the 70 kDa band moved slightly downwards to the molecular 
weight of 65 kDa and, therefore, to the same level as the faint band in the control 
sample. 
 
3.3.2 Analysis of the localisation of δ-ENaC protein in δ-ENaC over-
expressing H441 cells by means of immunofluorescence microscopy 
Additionally, immunofluorescence microscopy was carried out to further assess 
the localisation of δ-ENaC protein in the transfected H441 cells. Localisation of 
the δ-ENaC protein in H441 wild-type cells was compared to its localisation in 
100 kDa
70 kDa
β-actin
H441
DENaC
-PNGase
H441
DENaC
+PNGase
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H441 DENaC cells using two different polyclonal anti-δ-ENaC antibodies (SC, 
DAR). Cell nuclei were counterstained with propidium iodide. 
 
 
Figure 28 
Immunofluorescence microscopy for δ-ENaC (green) in non-transfected (wt) and δ1-ENaC 
over-expressing (δ1-ENaC, green) H441 cells grown on permeable filter inserts and 
incubated with anti-δ-ENaC SC (A) or DAR (B) antibodies. Cell nuclei were counterstained 
with propidium iodide (red).  
 
Figure 28 (A) shows confocal laser scanning micrographs of H441 wt and H441 
DENaC cells labelled with Santa Cruz anti-δ-ENaC antibody (green). Both cell 
types display an identical punctuate staining pattern, which is consistent with 
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predominantly intracellular localisation of δ-ENaC protein. Figure 28 (B) shows 
H441 wt and H441 DENaC cells stained with DAR anti-δ-ENaC antibody (green). 
In the wild-type H441 cells, again, punctuate staining is observed, however, of 
higher intensity than with SC antibody. Moreover, the staining is less diffuse. 
Thus, with clear accumulation of the fluorescent signal around the cell nuclei, it is 
not possible to state whether the protein is localised intracellularly in 
compartments, i.e. the endoplasmatic reticulum or the Golgi apparatus, or even 
expressed in the apical membrane.  In the δ1-ENaC over-expressing cells, the 
signal localisation is clearly different. The staining appears as a continuous layer 
above the cell nuclei, suggesting localisation of δ-ENaC protein in the apical cell 
membrane. 
As shown above, the immunostaining obtained with the SC antibody was much 
less distinct than the signal detected with DAR antibody. Moreover, no difference 
in the localisation or in the intensity of the fluorescent signal was observed 
between the wild-type and the transfected H441 cells, when SC antibody was 
used. 
 
3.3.3 Ussing chamber: Analysis of the δ-ENaC function in δ-ENaC over-
expressing H441 cells 
As shown in Figure 29, H441 wt cells monolayers exceeded TEER values of 400 
Ω•cm2 by day 6 in culture. Delta-ENaC over-expressing cells required 
approximately 4 days.  
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Figure 29 
Transepithelial electrical resistance of wild-type H441 (wt, passage 61) and δ-ENaC over-
expressing H441 (DENaC, passage p (+11)) cell monolayers grown on permeable filter 
inserts in course of the time in culture. Red dotted line symbolizes TEER = 400 Ω•cm2. 
Results are expressed as means ± SD (n = 6).  
 
 
As shown in Figure 30, H441 DENaC cells exhibited significantly higher basal 
short-circuit current values (8.91 ± 3.06 μA, n = 29) than H441 wt cells (4.2 ± 2.1 
μA, n = 10). 
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Figure 30 
Steady state short-circuit current values (basal ISC [μA]) of H441 wt (n = 10) and H441 
DENAC (n = 29) cell monolayers, obtained under standard conditions (apical and 
basolateral KRB; pH = 7.4) prior to the start of the measurements. Results are expressed as 
means ± SD. *, P < 0.01 vs. H441 wt. 
 
 
Characterisation of the basal currents in H441 wild-type and H441 DENaC cells 
Alpha- and δ-ENaC mediated currents differ in their sensitivity to amiloride. While 
small concentrations of amiloride, i.e. 10 µM, are sufficient to inhibit α-ENaC 
mediated currents, ~10-fold concentration is required to block δ-ENaC. To assess 
the contribution of α-ENaC and δ-ENaC channels to the total sodium currents 
across the cell monolayers of the wild-type and δ1-ENaC over-expressing H441 
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cells, experiments studying the concentration-dependence of current inhibition by 
amiloride in H441 wt and H441 DENaC cells were conducted.  
 
Figure 31 (A) compares the ISC responses of H441 wt and H441 DENaC cell 
monolayers to the subsequent application of 10 µM and 100 µM amiloride, 
respectively. A significant decrease in the ISC of 88.3 ± 5.9% was observed in 
H441 wt cells after administration of 10 µM amiloride (n = 9; P < 0.01). The ISC 
was further reduced by 100 µM amiloride to the level of 3.8 ± 4% (n = 9) of the 
initial current. This additional current decrease was significant (P < 0.01). In 
contrast, in δ1-ENaC over-expressing cells, treatment with 10 µM amiloride 
reduced the ISC by solely 26.3 ± 10.1% (n = 9). Addition of 100 µM amiloride led 
to a further decrease in the ISC, to the level of 20.3 ± 1.1% of the basal short-
circuit current (n = 3). Both effects were significantly different to the basal ISC (P < 
0.01). 
The major part of the currents in the H441 wt cells were inhibited by 10 µM 
amiloride, whereas in δ1-ENaC over-expressing cells these were only about 25%. 
100 µM amiloride were required to inhibit the bulk of the currents in H441 DENaC 
cells. Consequently, the currents across H441 DENaC monolayers were mostly 
δ-ENaC mediated (insensitive to 10 µM amiloride, however, inhibitable by 100 
µM), whilst α-ENaC channels were primarily responsible for current mediation in 
H441 wt cells.  
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Figure 31 
Quantification of responses to the apical application of 10 μM and 100 μM amiloride (A) as 
well as to the basolateral application of 1 mM ouabain (B) to the H441 wt and H441 DENaC 
cell monolayers. Results are expressed as means ± SD (n = 3). The statistical significance 
of the effects versus baseline is expressed as *, P < 0.01; versus the respective effects in 
the wild-type H441 cells as #, P < 0.01; 
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To exclude the possibility that the observed changes were due to an altered 
composition of the basal currents, caused by the transfection procedure, the 
contribution of sodium currents to the overall ion flow was studied in the H441 wt 
and H441 DENaC cells. To this end, ouabain, an inhibitor of the Na+/K+-ATPase, 
was used. 
The basolateral application of 1 mM ouabain led to a significant decrease in the 
ISC by 78.5 ± 19.4% (n = 5) and by 69.6 ± 5.5% (n = 4) in H441 wt and H441 
DENaC, respectively. Both effects were significantly different (P < 0.01) from 
baseline, however, not from each other (Figure 31(B)). This lead to the 
conclusion that the contribution of sodium currents to the total transepithelial ion 
transport was similar in H441 wt and H441 DENaC cells and, therefore, 
unaffected by δ-ENaC over-expression.  
 
Response to apical application of Evans blue, capsazepine and icilin 
Delta-ENaC-selective inhibitor Evans blue [47] inhibited short-circuit currents in 
both wild-type and δ1-ENaC over-expressing H441 cells (Figure 32 (A)). The 
suggested δ-ENaC-selective activator, capsazepine [54], inhibited sodium 
currents in H441 wt cells. In contrast, the compound had an activating effect on 
currents in H441 δ1-ENaC over-expressing cells (Figure 32 (B)). Icilin, also 
suggested as a selective δ-ENaC activator [58], increased the ISC of H441 
DENaC cell monolayers, as shown in Figure 32 (C), whilst, on the other hand, 
decreasing the ISC levels in H441 wild-type cells. 
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Figure 32 
Overlay of the representative current traces obtained in H441 wild-type (black line) and 
H441 DENAC cells (red line) after the administration of 100 μM and 300 μM EB (A), 20 μM 
capsazepine (B) and 60 μM icilin (C). 
 
 
Quantification of effects of the reported δ-ENaC modulators on the short-circuit 
currents in the wild-type and transfected H441 cells 
In order to quantify the pharmacological responses to the respective compounds, 
the ISC, measured 10 min after the application of the substance, were normalised 
to the basal ISC (Figure 33). 
66 
 
Figure 33 
Quantification of the responses to 100 μM and 300 μM Evans blue (EB), 20 μM 
capsazepine (caps) and 60 μM icilin in H441 wt and H441 DENaC cells. Short-circuit current 
values were measured 10 min after adding the compound and normalised to the baseline 
ISC (100%). Results are expressed as means ± SD (n = 3). The statistical significance of the 
effects versus H441 wt is expressed as *, P < 0.01. 
 
Administration of EB 100 μM lead to a decrease in ISC of 54.1 ± 22.5% and 52.6 ± 
11.0% in H441 DENaC and H441 wt cells (n = 3), respectively. After adding 300 
μM EB to H441 DENaC cell monolayers, a drop in the ISC of 63.5 ± 31.2% (n = 3) 
was observed. The difference between the effects of 100 μM and 300 μM EB was 
not significant in H441 DENaC cells. In contrast, in H441 wt cells, 300 μM EB 
resulted in an inhibition of 78.6 ± 11.5% (n = 3) of the basal ISC, and therefore, a 
significant additional inhibitory effect compared to 100 μM EB (P < 0.05). 
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However, there was no significant difference between the effects induced by 100 
μM and 300 μM EB between H441 DENaC and H441 wt cells, respectively. 
  
Furthermore, Figure 33 shows that capsazepine led to an increase in ISC of 31.4 
± 11.4% (n = 3) in H441 DENaC cells, but to a decrease in ISC of 25.3 ± 15.2% (n 
= 3) in H441 wt cells. The resulting short-circuit currents were significantly 
different from each other (P < 0.01). 
 
Similar was observed in the case of icilin. Administration of 60 μM icilin to H441 
DENaC cell monolayers resulted in an increase of ISC of 32.8 ± 12.1% (n = 3), as 
opposed to ISC decrease in H441 wt cells. The effects in both cell types were, 
hence, significantly different (P < 0.01). 
 
Amiloride-sensitivity of the capsazepine- and icilin-evoked currents in δ-ENaC 
over-expressing H441 cells 
In order to test the amiloride-sensitivity of the currents, activated by 
administration of capsazepine and icilin in δ-ENaC over-expressing H441 cells, 
the effects observed in the absence and the presence of 10 µM amiloride were 
studied and compared. After the basal ISC had stabilised, the monolayers were 
treated with 10 µM amiloride. After about 10 min, the respective compounds, 
capsazepine or icilin, were applied. The resulting effects reflect the amiloride-
insensitive (10 µM) component of the effects observed in the absence of 
amiloride. 
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Figure 34 
Quantification of the effects on short-ciruit currents in H441 cells, induced by 20 μM 
capsazepine (caps) in the absence and presence of 10 µM amiloride. Effects in the absence 
of amiloride represent the total pharmacological response, those in the presence of the 
amiloride, i.e., the amiloride-insensitive component. Short-circuit current values were 
measured 10 min after adding the compound and normalised to the baseline ISC (100%). 
Results are expressed as means ± SD (n = 3). The statistical significance of the effects 
versus baseline is expressed as *, P < 0.01; the statistical significance of the effects versus 
caps 20 µM is expressed as #, P < 0.01. 
 
As shown above, capsazepine acted as an activator of the short-circuit currents 
in δ1-EnaC over-expressing H441 cells. Figure 34 demonstrates the significant 
increase in the total current caused by 20 µM capsazepine (31.4 ± 11.4%, n = 3, 
P < 0.01). Treatment of H441 DENaC cell monolayers with 10 µM amiloride 
reduced the ISC by 19.2 ± 13.6% (n = 3) of the basal level. Due to a rather high 
standard deviation, the effect was not significant. Administration of 20 µM 
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capsazepine to amiloride-treated H441 DENaC monolayers lead to an increase in 
the ISC of 28.5 ± 4.8% (n = 3), compared to the ISC in the presence of amiloride. 
Thus, the extent of activation was similar for both, the total and the amiloride-
insensitive currents, suggesting that stimulation of currents insensitive to 10 µM 
amiloride accounted for the increase in total currents.  
Alpha- and δ-ENaC mediated currents differ in their sensitivity to amiloride. While 
small concentrations of amiloride, i.e., 10 µM, are sufficient to inhibit α-ENaC 
mediated currents, ~10-fold concentration is required to block δ-ENaC. Hence, 
the described observations suggest that capsazepine-induced currents were 
mediated by δ-ENaC, rather than by α-ENaC-containing channels.  
 
Icilin as an activator of δ-ENaC function, significantly increased the total currents 
of H441 DENaC by 32.8 ± 12% of basal ISC (n = 3, P < 0.01), as shown in Figure 
35. When added in the presence of 10 µM amiloride, icilin led to an increase of 
39.2 ± 2.7% of the amiloride-insensitive ISC (n = 3, P < 0.01). As in the case of 
capsazepine, it can be concluded that the icilin-induced increase in total current 
was mostly due to stimulation of currents insensitive to 10 µM amiloride. 
Therefore, stimulated currents were likely to be mediated by δ-ENaC, rather than 
by α-ENaC. 
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Figure 35 
Quantification of the effects on short-ciruit currents in H441 cells, induced by 60 μM icilin in 
the absence and presence of 10 µM amiloride. Effects in the absence of amiloride represent 
the total pharmacological response, those in the presence of the amiloride, i.e., the 
amiloride-insensitive component. Short-circuit current values were measured 10 min after 
adding the compound and normalised to the baseline ISC (100%). Results are expressed as 
means ± SD (n = 3). The statistical significance of the effects versus baseline is expressed 
as *, P < 0.01; versus 60 µM icilin as #, P < 0.01; versus 10 µM amiloride as +, P < 0.01. 
 
 
3.3.4 Patch-clamp experiments 
Transepithelial measurements in modified Ussing chambers allow to investigate 
the effects of pharmacological modulators, e.g., channel activators or blockers, 
on the ion transport across confluent cell monolayers. Patch-clamp technique, on 
the other hand, facilitates to study the ion transport across the membrane of a 
single cell (whole-cell mode) or even via a single channel (single channel mode). 
To confirm the findings obtained with δ-ENaC modulators in Ussing chamber 
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studies, patch-clamp experiments were carried out using H441 DENaC cells 
(passage (+8) - (+12)). Only isolatedly growing cells were used in these studies. 
All experiments were conducted in the whole-cell mode. 
 
 
Figure 36 
Representative whole-cell current trace from a H441 DENaC cell recorded at the holding 
potential of -60mV.  
 
Membrane currents of cations are negative when ions move inward, as shown in 
Figure 36, a representative whole-cell current trace recorded in a H441 DENaC 
cell. The slight positive shift in the current from -70nA to -50nA, after the 
application of 10 µM amiloride, underlines that the recorded traces are inhibited 
by amiloride. Capsazepine as an activator, on the other side, results in a more 
negative current (-90nA) then the initial value caused by the bigger inward flux of 
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sodium ions. The agonistic impact of capsazepine is partially abolished by a 
reapplication of amiloride. 
 
Figure 37 shows the quantification of the observed effects. 25.8 ± 7.0% (n = 3) of 
the sodium currents were inhibited by amiloride in H441 DENaC cells, whereas 
capsazepine activated currents by 40.9 ± 15.0% (n = 3) (P < 0.01). In 
capsazepine-treated cells, 20.4 ± 11.7% of the measured current were amiloride-
sensitive. 
These data confirm that capsazepine activated sodium currents in δ-ENaC over-
expressing cells. The stimulation of the ion transport occurred not only across the 
intact, confluent cell monolayer (Ussing chamber) but also on the single cell level 
(patch-clamp). Moreover, this stimulation was mostly due to activation of currents 
insensitive to 10 µM amiloride (Figure 37) and, therefore, not α-ENaC mediated. 
This is consistent with our previous findings in the Ussing chamber experiments 
(Figure 34).  
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Figure 37 
Effects of amiloride and capsazepine on the sodium currents in H441 DENaC cells, 
measured by patch-clamp technique in the whole-cell configuration. Results are expressed 
as means ± SD (n = 3). The statistical significance of the effects versus currents measured 
in the bath solution is expressed as *, P < 0.01. 
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4 DISCUSSION 
The aim in this thesis was to investigate the expression, cellular localisation and 
function of δ-ENaC in human respiratory epithelial cells as well as to determine 
the δ-ENaC specificity of the modulators’ effects observed in H441 and Calu-3 
cells. 
The Western blot and IFM data imply that δ-ENaC is in fact expressed in H441 
and Calu-3 wild-type cells on protein level, confirming previous publications by 
other groups that state the expression of δ-ENaC in H441 cells [20] and human 
nasal epithelium [21]. However, results of cell surface protein biotinylation 
suggest that it is not or only marginally expressed in the cell membranes. 
RNAi experiments aiming to silence the expression of δ-ENaC protein were 
performed, but failed to show significantly less pronounced band intensities in 
shRNA transfected cells. The reason for this seemingly unsuccessful attempt of 
down-regulating the δ-ENaC expression might lie in an already rather low 
expression level of δ-ENaC in H441 and Calu-3 wt cells. Therefore, further down-
regulation does not show a difference in expression levels. 
An alternative approach for investigating the expression and localisation was the 
over-expression of δ-ENaC protein in H441 cells. To this end, cells were 
transfected with δ1-ENaC plasmid. The immunoblots of the biotinylated samples 
demonstrated the presence of δ-ENaC protein in both apical and basolateral 
membranes. Interestingly, higher amounts of δ1-ENaC protein were observed in 
the basolaterally biotinylated samples. This was rather unexpected since ENaC 
channels are usually localised in the apical membranes [1, 2]. Furthermore, 
Na+/K+-ATPase, as a basolateral marker, was not detected in either of the 
biotinylated samples, which leads to the conclusion, that the biotinylated cell 
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lysates might have been deficient. Deglycosylation of cell lysates with PNGase F 
indicates that the 65 kDa band, which also appears in the H441 DENaC whole-
cell immunoblots, represents the non-glycosylated δ1-ENaC protein. 
Immunofluorescence microscopy demonstrated that the over-expressed δ1-ENaC 
protein is localised in the apical membrane of H441 DENaC cells. Compared to 
IFM images of H441 wt cells there is a distinct difference in the localisation 
pattern, adding to our thesis that in wild-type cells δ-ENaC is not expressed in the 
apical membrane but rather intracellular or in certain cellular compartments. 
Ji et al. reported evidence of δ-ENaC expression in H441 and A549 cells on 
mRNA level and protein level. They, however, did not provide functional data in 
these organotypic cell models but instead used heterologous expression systems 
for patch-clamp experiments [20]. 
To underline our assumption with functional data, Ussing chamber 
measurements were carried out with wild-type, δ-ENaC mock-transfected and 
down-regulated cells (H441, Calu-3) as well as with δ-ENaC over-expressing 
cells (H441). Each compound had a significant impact on the short-circuit 
currents in the wild-type and the transfected cells, adding to the assumption that 
a low membrane abundance could not be down-regulated further or rather does 
not result in an observably different effect of the channel’s function. 
Moreover, the studies conducted in our lab have shown that the three 
compounds suggested as selective δ-ENaC modulators had a different impact on 
the short-circuit currents in H441 and Calu-3 wild-type and RNAi transfected cells 
than the effects reported by other research groups in heterologous expression 
systems [47, 54, 58] and native tissue [21]. 
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In contrast to our previous experiments with H441 wt cells, in which currents were 
inhibited by capsazepine and icilin, currents in δ1-ENaC over-expressing H441 
monolayers were activated by capsazepine and icilin. Evans blue exhibited 
inhibitory effects on the short-circuit currents in both cell types.  
Taking the results of δ-ENaC over-expression into account, it can be concluded 
that the responses in H441 wt as well as in Calu-3 wt monolayers were not δ-
ENaC specific. Hence, like in H441 cells, δ-ENaC protein, albeit being present 
according to Western blot results, does not play a functional role in Calu-3 and 
H441 wild-type cells due to low membrane abundance. 
To determine the contribution of α-ENaC and δ-ENaC channels to the total 
sodium currents in H441 wt and H441 DENaC cells, experiments studying the 
concentration dependence of the current inhibition by amiloride were conducted. 
While α-ENaC currents are inhibited by small concentrations of amiloride (10µM), 
~10-fold concentration is required to block δ-ENaC. Regarding H441 wt cells, the 
major part of the current was blocked by the administration of 10 µM amiloride, 
which lead to the conclusion that currents in H441 wild-type cells are mainly 
mediated by α-ENaC and αβγ-ENaC channels. In contrast, the responses in 
H441 DENaC cells were significantly different, with the major portion of the 
current being insensitive to 10 µM, however, inhibitable by 100 µM amiloride.  
Subsequently, to confirm that the pharmacological responses, observed in H441 
DENaC cells, mainly originated from the interactions of the respective 
compounds with δ1-ENaC channels, the amiloride-sensitivity of the induced 
currents was tested. Although H441 DENaC monolayers were pre-treated with 10 
µM amiloride and, hence, α-ENaC channels were inhibited, both capsazepine 
and icilin were still able to stimulate currents. These results confirm that the 
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current activation caused by capsazepine and icilin was due to activation of δ1-
ENaC channels. Patch-clamp studies in whole-cell modification underlined the 
stimulatory effect of capsazepine on the sodium currents in δ-ENaC over-
expressing H441 cells. Moreover, the effects were shown to be insensitive to 10 
µM amiloride and, therefore, mediated by δ- rather than by α-ENaC channels.  
Although Ussing chamber experiments, using H441 wt cell monolayers in 
standard KRB and sodium-free buffer, suggest that the pharmacological 
responses to δ-ENaC modulators were sodium-dependent, the responses to the 
individual compounds, we observed in organotypic and δ-ENaC down-regulated 
cell models, were not in accordance with those described in heterologous 
expression systems. All three substances are known to interact with proteins 
other than δ-ENaC. Evans blue is said to activate large-conductance Ca2+-
activated K+ channels [60, 61]. Capsazepine is a competitive antagonist of 
TRPV1 [48, 49, 50]; furthermore, it blocks voltage-dependent calcium and 
potassium channels [51, 52]. Icilin works as an agonist for the transient receptor 
potential melastatin subfamily 8 and ankyrin-like subfamily 1 [55, 56, 57, 62]. 
Contrary to others, we are assuming that the compounds’ effects, observed in our 
hands, most likely originated from modulation of other targets and that the 
compounds are not necessarily δ-ENaC specific. The reason that the effects 
observed in δ-ENaC over-expressing H441 cells match the effects observed by 
Yamamura and others [47, 54, 58], but are different from effects recorded in 
organotypic cell models, might be caused by effects, mediated by δ-ENaC 
channels, that are overlaying the effects mediated by the other targets. 
Furthermore, the affinity of the respective compounds to δ-ENaC might be higher 
than the affinity to other targets. Moreover, it might be the case that not all of the 
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above-mentioned targets are present in X. laevis oocytes. Additionally, Bangel-
Ruland draws a conclusion on the δ-ENaC specificity by using only one δ-ENaC 
modulator [21]. Therefore, the usage of these compounds as tools for 
characterisation of δ-ENaC function in native cells is rather limited. 
In conclusion, we found that the δ-ENaC subunit is expressed in H441 and Calu-
3 cells on protein level, although it does not seem to play a physiological role in 
respiratory epithelial cells due to low membrane abundance. However, in order to 
further study the functional expression as well as the physiological role of δ-
ENaC in the lung epithelium, but also in other tissues, additional investigations 
aiming to identify specific δ-ENaC modulators are needed. 
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5 SUMMARY 
The epithelial sodium channel (ENaC) is an amiloride-sensitive, non-voltage 
gated ion channel, which is widely distributed throughout epithelial as well as 
non-epithelial tissues. Alpha-, β- and γ-subunits are predominantly found in 
epithelial tissues, i.e., in the lung and kidney. In the lung, αβγ-ENaC plays a 
crucial role at birth, when the lung changes from the liquid-filled to the air-filled 
state. In addition, δ-ENaC subunit mRNA and protein are present in the human 
lung tissue, raising the question about the physiological role of δ-ENaC in this 
organ. A number of xenobiotics have been suggested to be selective δ-ENaC 
modulators, i.e., Evans blue (inhibitor) as well as capsazepine and icilin 
(activators). In this study, our aim was to investigate the expression, cellular 
localisation and function of δ-ENaC in human respiratory epithelial cells. 
Furthermore, we assessed the specificity of the mentioned δ-ENaC modulators. 
 
First, we studied the sodium-dependence of the alleged activators’ and inhibitors’ 
effects in H441 cells. To this end, Ussing chamber experiments were carried out 
in Krebs-Ringer-Buffer (KRB) and in sodium-free KRB. In contrast to previously 
published studies, all of the above mentioned compounds displayed inhibitory 
effects in H441 cells in KRB. In sodium-free buffer, however, none of the 
substances led to significant changes in ISC, indicating a sodium-dependence of 
the observed effects. 
 
Since the compounds’ effects in our hands were different from the previous 
observations by others, we tested the δ-ENaC specificity of the effects by 
silencing (H441 and Calu-3) as well as over-expressing (H441) δ-ENaC. First, the 
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effects of the stable knock-down of the δ-ENaC protein in H441 and Calu-3 cells 
were assessed on the protein level by Western blot analysis. Moreover, the 
effects of δ-ENaC modulators on the currents in transfected, mock-transfected 
and non-transfected cells were compared. However, no significant reduction was 
detected in protein abundance and in the modulators’ effects in the δ-ENaC 
knockdown-transfectants, suggesting that the attempt to down-regulate the 
expression and function of δ-ENaC was not successful. 
The over-expression of δ-ENaC in H441 cells was also assessed by Western blot 
and Ussing chamber experiments. Furthermore, immunofluorescence microscopy 
(IFM) and patch-clamp studies were carried out. After the transfection with δ1-
ENaC plasmid, H441 clones stably over-expressing δ-ENaC protein, as 
confirmed by Western blot, were selected, expanded and used for subsequent 
analysis. IFM revealed the localisation of the over-expressed δ-ENaC channels in 
the apical cell membrane. In contrast to the effects in the wild-type H441 cells, 
currents in δ1-ENaC over-expressing H441 monolayers were activated by 
capsazepine and icilin. Evans blue exhibited inhibitory effects on the short-circuit 
currents in both cell types. Patch-clamp studies confirmed that the current 
activation caused by capsazepine was due to activation of δ1-ENaC channels.  
Collectively, our observations revealed that the compounds’ effects in the 
organotypic cell models likely originated from modulation of other, yet unknown, 
targets different from δ-ENaC. Thus, under the chosen, unstimulated conditions, 
δ-ENaC did not contribute to the transepithelial sodium transport across the 
respiratory epithelium. In addition, the reported δ-ENaC modulators were proven 
to be of a limited suitability for use in organotypic cell models. Therefore, the 
identification of more and more specific δ-ENaC modulators is required in order 
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to study the functional expression as well as the physiological role of δ-ENaC in 
the lung epithelium and other tissues. 
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6 ZUSAMMENFASSUNG 
Amilorid-sensitive und spannungsunabhängige epitheliale Natriumkanäle (ENaC) 
sind sowohl in epithelialem als auch in nicht-epithelialem Gewebe weit verbreitet; 
wobei α-, β- und γ-Untereinheiten überwiegend in epithelialem Gewebe, z.B. der 
Lunge und der Niere, vorkommen. Im Respirationstrakt spielt αβγ-ENaC eine 
entscheidende Rolle während der Geburt, wenn die Lunge von einem mit 
Flüssigkeit gefüllten zu einem Luft-gefüllten Organ wird. Delta-ENaC mRNA und 
Protein sind in der menschlichen Lunge ebenfalls vorhanden. Daraus ergibt sich 
die Frage nach der physiologische Funktion δ-ENaCs im Lungenepithel. Als 
spezifische δ-ENaC Modulatoren wurden Evans blue (Antagonist) sowie 
Capsazepin und Icilin (Agonisten) in der Literatur genannt. Unser Ziel war, die 
Expression, Lokalisation und Funktion von δ-ENaC in Epithelzellen des 
menschlichen Respirationstraktes genauer zu untersuchen, sowie in weiterer 
Folge die Spezifität der δ-ENaC Modulatoren zu beurteilen. 
 
Als Erstes wurde die Natriumabhängigkeit der, durch die mutmaßlichen 
Agonisten und Antagonisten, hervorgerufenen Effekte in H441 Zellen untersucht. 
Hierzu wurden Ussingkammerstudien sowohl in Krebs-Ringer-Puffer (KRP) als 
auch in Natrium-freien KRP ausgeführt. Es konnte eine definitive 
Natriumabhängigkeit der beobachteten Effekte festgestellt werden, da keine der 
Verbindungen zu einer signifikanten Änderung der ISC in Natrium-freiem KRP 
führte. In regulärem KRP hingegen wurde bei allen Substanzen eine inhibierende 
Wirkung festgestellt. 
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Da die von uns beobachteten Effekte von denen in vorherigen Publikationen 
abwichen, haben wir versucht die δ-ENaC Spezifität der verwendeten 
Substanzen durch δ-ENaC Herabregulierung (H441 und Calu-3) und durch 
Überexpression (H441) genauer zu eruieren. 
Die stabile Herabregulierung des δ-ENaC Proteins in H441 und Calu-3 Zellen 
wurde anhand von Western blot Analysen beurteilt. Danach wurden die Effekte 
der δ-ENaC Modulatoren auf die Elektrophysiologie transfizierter Zellen mit den 
Effekten auf Kontroll-transfizierten und nicht-transfizierten Zellen verglichen. Da 
weder bei der Proteinmenge noch bei den modulatorischen Effekten eine 
signifikante Abnahme zu erkennen war, kann von einer erfolglosen 
Herabregulierung der δ-ENaC Expression ausgegangen werden. 
In weiterer Folge wurde die stabile Überexpression von δ-ENaC durchgeführt. 
Nach der Transfektion der H441 Zellen mit dem δ1-ENaC Plasmid, wurden die 
überexprimierenden Klone mittels Western blot Analyse bestimmt und danach 
vermehrt. Anhand der Immunofluoreszenzmikroskopie konnten die δ-ENaC 
Kanäle in der apikalen Zellmembran lokalisiert werden. Im Gegensatz zu den 
Wildtyp Zellen wurden die Kanäle in δ-ENaC überexprimierenden Zellen durch 
Capsazepin und Icilin aktiviert und durch Evans blue inhibiert. Patch-clamp 
Experimente festigten die Annahme, dass die aktivierende Wirkung von 
Capsazepin durch δ1-ENaC vermittelt wurde. 
Diese Ergebnisse führen zu dem Schluss, dass unsere Beobachtungen in 
organotypischen Zellmodellen wahrscheinlich auf der Modulation anderer 
Zielstrukturen basieren. Da sich die Modulatoren somit als nur bedingt δ-ENaC 
spezifisch herausstellten, ist die Ermittlung weiterer, δ-ENaC spezifischerer 
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Verbindungen dringend notwendig, um sowohl die Expression als auch die 
physiologische Funktion von δ-ENaC zu untersuchen. 
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